Type

Article

Sustainable Development Goals

03 Saúde e Bem-Estar

Author

Affilliation

Keywords in Portuguese

Vírus Chikungunya
Vírus O'nyong-nyong
História natural de doenças
Soroprevalência
Epidemiologia

Keywords

Chikungunya virus
O'nyong-nyong Virus
Natural History of Diseases
Soroprevalence
Epidemiology

Citation

PEZZI, L. et al. GloPID-R report on chikungunya, o'nyong-nyong and Mayaro virus, part 3: Epidemiological distribution of Mayaro virus. Antiviral Research, v. 172, p. 1-10, 2019.

DOI

10.1016/j.antiviral.2019.104610

ISSN

0166-3542

Notes

Ribeiro, Guilherme de Sousa. Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.
Lourenço-de-Oliveira, R.; Rosa-Freitas, M. G. Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Mosquitos Transmissores de Hematozoários. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.
Siqueira, A. M. Fundação Oswaldo Cruz. Instituto Nacional de Pesquisa Clínica Evandro Chagas. Rio de Janeiro, RJ, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento.
a Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France b EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France c Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia d Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands e Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands f Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Federal University of Bahia, Salvador, Brazil g Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA h Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil i Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil j Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France k Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France l Établissement Français du Sang Alpes Méditerranée, Marseille, France m Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany n Laveran Military Teaching Hospital, Marseille, France o Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de la Guadeloupe, Guadeloupe p Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, alveston, USA q Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Institute of Virology, 10117, Berlin, Germany r German Centre for Infection Research (DZIF), Germany s Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA t Medical Entomology Platform, Institut Pasteur du Cambodge, Phnom Penh, Cambodia u Blood Systems Research Institute, San Francisco, Department of Laboratory Medicine, University of California, San Francisco, USA v Unité d'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal w Department of Medicine, The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA x Department of Molecular Microbiology, The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA y Department of Pathology and Immunology, The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA z Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada aa MRC-University of Glasgow Centre for Virus Research, Glasgow, UK ab KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium ac Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore ad Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ae Blood Systems Research Institute, San Francisco, USA af Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA.